ISBN: 1607614669
[EAN: 9781607614661], Neubuch, Publisher/Verlag: Springer, Berlin | Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakth… More...
AbeBooks.de English-Book-Service - A Fine Choice, Waldshut-Tiengen, Germany [1048135] [Rating: 4 (von 5)] NEW BOOK Shipping costs:Versandkostenfrei (EUR 0.00) Details... |
2013, ISBN: 9781607614661
Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of th… More...
Orellfuessli.ch No. 17938214. Shipping costs:Zzgl. Versandkosten. (EUR 16.09) Details... |
ISBN: 9781607614661
Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of th… More...
Thalia.de No. 17938214. Shipping costs:, Lieferbar in 2 - 3 Wochen, DE. (EUR 0.00) Details... |
2013, ISBN: 9781607614661
Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of th… More...
Orellfuessli.ch Nr. 17938214. Shipping costs:, wird besorgt, Lieferzeit unbekannt, zzgl. Versandkosten, Lieferzeiten außerhalb der Schweiz 3 bis 21 Werktage. (EUR 16.71) Details... |
2013, ISBN: 9781607614661
Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of th… More...
Orellfuessli.ch Nr. 17938214. Shipping costs:Does not ship to your country., plus shipping costs Details... |
ISBN: 1607614669
[EAN: 9781607614661], Neubuch, Publisher/Verlag: Springer, Berlin | Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakth… More...
2013, ISBN: 9781607614661
Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of th… More...
ISBN: 9781607614661
Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of th… More...
2013, ISBN: 9781607614661
Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of th… More...
2013, ISBN: 9781607614661
Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of th… More...
Bibliographic data of the best matching book
Author: | |
Title: | |
ISBN: |
Details of the book - Breast Cancer in the Post-Genomic Era
EAN (ISBN-13): 9781607614661
ISBN (ISBN-10): 1607614669
Hardcover
Paperback
Publishing year: 201307
Publisher: Springer
230 Pages
Language: Englisch
Book in our database since 2009-10-31T18:21:07+00:00 (London)
Detail page last modified on 2021-06-05T20:18:20+01:00 (London)
ISBN/EAN: 1607614669
ISBN - alternate spelling:
1-60761-466-9, 978-1-60761-466-1
Alternate spelling and related search-keywords:
Book author: giordano
Book title: cancer the breast, post
Information from Publisher
Author: Antonio Giordano; Nicola Normanno
Title: Current Clinical Oncology; Breast Cancer in the Post-Genomic Era
Publisher: Humana Press
230 Pages
Publishing year: 2013-09-01
Printed / Made in
Language: English
79,29 € (DE)
81,51 € (AT)
115,00 CHF (CH)
Available
BC; PB; Hardcover, Softcover / Medizin/Klinische Fächer; Klinische und Innere Medizin; Verstehen; Mammory Glands; Breast Cancer; Gene Expression; TGF-B Signaling; Breast Cancer therapy; Genomic Basis; Professional/practitioner; BB
Potential Contributors and Temptative Titles Section I: The biology of the mammary gland: Jose Russo, Breast Cancer Research Laboratory, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA Title: Mammary gland development Gilbert H. Smith Mammary Biology and Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, 9000 Rockville Pike, Bethesda, 20892, Maryland Title: Mammary gland, stem cells and breast cancer Section II: The genetic background of breast cancer Barbara L. Weber, Abramson Family Cancer Research Institute, University of Pennsylvania Cancer Center, 514 BRB II/III, 421 Curie Blvd, Philadelphia, PA 19104, USA Title: The genetic of breast cancer: application in clinical practice Ashok R. Venkitaraman, University of Cambridge, CR UK Department of Oncology and The Medical Research Council Cancer Cell Unit, Hutchison/MRC Research Centre, Hills Road, Cambridge, CB2 2XZ, U.K Title: Cancerogenesis associated with mutations in BRCA genes Section III: Epigenetic and molecular alterations in breast cancer Nancy E. Davidson, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, Room 409, Baltimore, MD 21231 Title: DNA methylation in breast cancer Antonio Giordano, Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, 1900 North 12th Street, Philadelphia, PA 19122, USA Title: Alterations of cell cycle regulatory genes in breast cancer David S. Salomon, Tumor Growth Factor Section, Mammary Biology & Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bldg 10, Rm. 5B39, Bethesda, Maryland 20892 Title: Role of the cripto (EGF-CFC) family in mammary gland development and neoplasia William J Gullick, Department of Biosciences, University of Kent at Canterbury, Canterbury, Kent CT2 7NJ Title: Type I growth factor receptors and their ligands in breast cancer: clinical significance and future prospects for treatment William J. Muller, Institute for Molecular Biology and Biotechnology, Department of Biology, McMaster University, Hamilton, Ontario, Canada L8S 4K1 Title: Transgenic mouse models of breast cancer as model to study oncogene mediated signal transduction Section IV: New tools for diagnosis and prognostic assessment in breast cancer Eric S. Lander, Whitehead Institute/MIT Center for Genome Research, One Kendall Square, Building 300, Cambridge, Massachusetts 02139, USA Title: Gene expression profiling in breast cancer: clinical applications Emanuel F. Petricoin III, Center for Applied Proteomics and Molecular Medicine, George Mason University, 10900 University Boulevard, MS 4E3, Manassas, VA 20110 Title: Proteomics in breast cancer Section V: Novel therapeutic approaches Erik P. Winer, Dana-Farber Cancer Institute, 44 Binney St, D1210, Boston, MA 02115, USA. Title: The endocrine therapy of breast cancer in the era of the aromatase inhibitors Nicola Normanno, Cell Biology and Preclinical Models Unit, INT-Fondazione Pascale, Naples, Italy Title: Signal transduction inhibitors for treatment and prevention of breast cancer Jose Baselga, Vall d'Hebron, University Hospital, Department of Medical Oncology, Pg Vall d'Hebron, 119-129, E-08035 Barcelona, Spain. Title: Monoclonal antibodies in breast cancer therapy: current status and future development Carlos L. Arteaga, Department of Cancer Biology, Vanderbilt University Medical Center, 2220 Pierce Avenue, 777 PRB, Nashville, TN 37232 USA Title: TGFbeta antagonists: a novel approach fro treatment of breast cancer? Francesco Perrone, Clinical Trials Unit, INT-Fondazione Pascale, Naples, Italy Integration of target based agents in current protocols of breast cancer therapyMore/other books that might be very similar to this book
Latest similar book:
9781603279451 Breast Cancer in the Post-Genomic Era (Springer)
< to archive...